Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne R Thibodeaux

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Clinical Apheresis|November 13, 2019
Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patientsRay Zhang, Aaron B Dahl, Bryan Marchant, et al.
Aging Cell|March 1, 2012
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cellsLishi Sun, Vincent J Hurez, Suzanne R Thibodeaux, et al.
Transfusion|March 16, 2023
Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative studySuzanne R Thibodeaux, Dean Coble, Victoria Day, et al.
Journal of Clinical Apheresis|January 27, 2022
Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studiesSuzanne R Thibodeaux, Nicole A Aqui, Yara A Park, et al.
Cytotherapy|April 10, 2022
Considerations for immune effector cell therapy collections: a white paper from the American Society for ApheresisHien D Liu, Leon Su, Jeffrey L Winters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian CancerSuzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.
Experimental Parasitology|April 2, 2013
TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide productionMichael J Brumlik, Srilakshmi Pandeswara, Sara M Ludwig, et al.
Cytotherapy|September 29, 2025
Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for ApheresisNicole A Aqui, Patricia A Shi, Yara A Park, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Apheresis|November 13, 2019
Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patientsRay Zhang, Aaron B Dahl, Bryan Marchant, et al.
Aging Cell|March 1, 2012
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cellsLishi Sun, Vincent J Hurez, Suzanne R Thibodeaux, et al.
Transfusion|March 16, 2023
Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative studySuzanne R Thibodeaux, Dean Coble, Victoria Day, et al.
Journal of Clinical Apheresis|January 27, 2022
Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studiesSuzanne R Thibodeaux, Nicole A Aqui, Yara A Park, et al.
Cytotherapy|April 10, 2022
Considerations for immune effector cell therapy collections: a white paper from the American Society for ApheresisHien D Liu, Leon Su, Jeffrey L Winters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian CancerSuzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Cancer Research|April 13, 2012
Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged miceVincent Hurez, Benjamin J Daniel, Lishi Sun, et al.
Experimental Parasitology|April 2, 2013
TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide productionMichael J Brumlik, Srilakshmi Pandeswara, Sara M Ludwig, et al.
Cytotherapy|September 29, 2025
Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for ApheresisNicole A Aqui, Patricia A Shi, Yara A Park, et al.
Pageof 3